Applying LymphGen Classification to a Clinically Validated 400-gene Targeted Next-Generation Sequencing (NGS) Panel in Diffuse Large B-cell Lymphoma (DLBCL)

被引：0
|
作者：
Zhu, Menglei [1 ]
Drill, Esther [1 ]
Joffe, Erel [1 ]
Arcila, Maria [1 ]
Dogan, Ahmet [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
975
引用
收藏
页码：1056 / 1058
页数：3
相关论文
共 50 条
  • [41] Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA
    Stokowski, Renee P.
    Tabari, Ehsan
    Bogard, Patrick
    Hacker, Coleen
    Kameneva, Olga K.
    Ji, Tieming
    Teng, Li
    Melnikova, Vladislava
    McCord, Ron
    Punnoose, Elizabeth A.
    Loberg, Robert
    Shabbeer, Junaid
    BLOOD, 2022, 140 : 9257 - 9258
  • [42] Reliability of the detection of the mutation burden status by targeted next generation sequencing applying a large gene panel
    Pfarr, N.
    Boxberg, M.
    Riedmann, K.
    Jesinghaus, M.
    Konukiewitz, B.
    Glimm, H.
    Jost, P. J.
    Froehling, S.
    Weichert, W.
    ANNALS OF ONCOLOGY, 2018, 29
  • [43] Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
    Abdulhaq, Haifaa
    Hwang, Andrew
    Mahmood, Omar
    ONCOTARGETS AND THERAPY, 2023, 16 : 617 - 629
  • [44] Next Generation Sequencing Analysis Reveals Characteristic Genetic Alterations in Double Expressor Diffuse Large B-cell Lymphoma
    Liu, Lu
    Jiang, Xiang Nan
    Yao, Qianlan
    Li, Fan-Ping
    Zhou, Xiaoyan
    Li, Xiao-Qiu
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1442 - S1443
  • [45] Detection of the mutation burden status and microsatellite instability by targeted next generation sequencing applying a large gene panel
    Pfarr, N.
    Boxberg, M.
    Riedmann, K.
    Jesinghaus, M.
    Konukiewitz, B.
    Glimm, H.
    Jost, P. J.
    Froehling, S.
    Weichert, W.
    VIRCHOWS ARCHIV, 2019, 475 : S104 - S104
  • [46] Inter-site performance comparison of a next generation sequencing (NGS) assay for minimal residual disease detection research in diffuse large B-Cell lymphoma (DLBCL) using plasma circulating tumor DNA (ctDNA)
    Woestmann, Corinna
    Lin, Hai
    McNamara, Sylvie
    Shin, Maria
    Bermejo, Clara
    Hammer, Sabrina
    Heitzer, Ellen
    Blombery, Piers
    Yaung, Stephanie
    Su, Bowdoin
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Factors Affecting the Performance of Next-Generation Sequencing (NGS) Assays: Experience with the NVIGEN 180 Gene Targeted NGS Panel Cancer Precision Profiling Assay
    Fu, A.
    Ton, M.
    Wang, K.
    Gu, W.
    Li, T.
    Liu, M.
    Parsons, H.
    Sledge, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S127 - S128
  • [48] Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
    Lohr, Jens G.
    Stojanov, Petar
    Lawrence, Michael S.
    Auclair, Daniel
    Chapuy, Bjoern
    Sougnez, Carrie
    Cruz-Gordillo, Peter
    Knoechel, Birgit
    Asmann, Yan W.
    Slager, Susan L.
    Novak, Anne J.
    Dogan, Ahmet
    Ansell, Stephen M.
    Link, Brian K.
    Zou, Lihua
    Gould, Joshua
    Saksena, Gordon
    Stransky, Nicolas
    Rangel-Escareno, Claudia
    Carlos Fernandez-Lopez, Juan
    Hidalgo-Miranda, Alfredo
    Melendez-Zajgla, Jorge
    Hernandez-Lemus, Enrique
    Schwarz-Cruz y Celis, Angela
    Imaz-Rosshandler, Ivan
    Ojesina, Akinyemi I.
    Jung, Joonil
    Pedamallu, Chandra S.
    Lander, Eric S.
    Habermann, Thomas M.
    Cerhan, James R.
    Shipp, Margaret A.
    Getz, Gad
    Golub, Todd R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (10) : 3879 - 3884
  • [49] Investigating novel targeted therapies for double hit diffuse large B-cell lymphoma (DH-DLBCL)
    Patel, Priyank P.
    Zeccola, Alison
    Gu, Juan
    Mavis, Cory
    Sait, Sheila N. J.
    Neppalli, Vishala
    Hernandez-Ilizaliturri, Francisco J.
    CANCER RESEARCH, 2016, 76
  • [50] Next-generation sequencing (NGS) detects presence of chimeric antigen receptor (CAR) T-cell construct in a diffuse large B-cell lymphoma patient with no response to CAR T-cell therapy: a case report
    Aishwarya Sridhar
    Dylon Patel
    Alexandra Della Pia
    Tatyana A. Feldman
    Lori A. Leslie
    Andre H. Goy
    Maher Albitar
    Andrew Ip
    Discover Medicine, 2 (1):
12345